– ARA290 (Cibinetide)

Price range: $75.00 through $100.00

Product Classification

Classified as an EPO-derived tissue protective peptide

Description

ARA290 (Cibinetide) is a small peptide derived from erythropoietin (EPO) designed to selectively engage the innate repair receptor (IRR) without erythropoietic effects.
Research explores neuroprotection, nociceptive modulation, inflammatory signaling, and vasculopathy models.

Specifications

  • Molecular Type: EPO-derived non-erythropoietic peptide
  • Mechanism : Mechanism IRR activation and tissue protective signaling

Research Notes

  • Neuropathic Pain: studies in diabetic neuropathy models report nociceptive modulation.
  • Microvascular: interest in microcirculatory dysfunction and endothelial protection.
  • Immunomodulation: anti-inflammatory cytokine balance and tissue repair pathways observed in
    preclinical work.
  • Erythropoiesis-Sparing: avoids hematologic responses typical of EPO derivatives.
Regulatory Statement

For research use only. Not for human or animal consumption.

Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent disease.

SKU: N/A Category:

Additional information

Strength

10mg, 16mg

Reviews

There are no reviews yet.

Be the first to review “– ARA290 (Cibinetide)”

Your email address will not be published. Required fields are marked *